Skip to main
IRTC

iRhythm Technologies (IRTC) Stock Forecast & Price Target

iRhythm Technologies (IRTC) Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 50%
Buy 42%
Hold 8%
Sell 0%
Strong Sell 0%

Bulls say

iRhythm Holdings Inc. reported a gross margin of 71.1%, an increase of 230 basis points year-over-year, which surpassed consensus estimates and indicates strong operational efficiency. The company anticipates a revenue outlook of $870-$880 million for 2025, reflecting a year-over-year growth of 16-18%, driven by robust performances in its ZIO systems and strong pricing mix. Additionally, iRhythm is expected to see notable improvements in EBITDA margins, projecting around 400 basis points of annual enhancement, which suggests strong potential for profitability and continued growth in the digital healthcare market.

Bears say

iRhythm Holdings Inc. faces significant challenges that contribute to a negative outlook, including expectations of slowing growth projected to reach only the low-teens and sluggish profitability improvements. The company's pricing is anticipated to remain flat through 2026 amid competitive pressures and risks associated with commercial reimbursement rates, which may be negatively impacted by broader market dynamics in the extended-wear cardiac monitoring sector. Additionally, iRhythm's adjusted operating expenses, despite a slight year-over-year decrease, include substantial investment in research and development, highlighting the financial strain from the need to innovate while navigating increasing competition and potential sales execution problems.

iRhythm Technologies (IRTC) has been analyzed by 12 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 42% recommend Buy, 8% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of iRhythm Technologies and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About iRhythm Technologies (IRTC) Forecast

Analysts have given iRhythm Technologies (IRTC) a Buy based on their latest research and market trends.

According to 12 analysts, iRhythm Technologies (IRTC) has a Buy consensus rating as of Mar 22, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $208.58, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $208.58, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

iRhythm Technologies (IRTC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.